Organization | Hangzhou First People Hospital

Hangzhou First People Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2011

NCT01431781

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Affilated Hangzhou First People Hospital | The Affiliated Hangzhou First People's Hospital

Active Ingredients

Drugs in Other Trials (7)

citalopram (celexa) (2 trials)

escitalopram (lexapro) (2 trials)

fluoxetine (prozac) (2 trials)

fluvoxamine (luvox) (2 trials)

paroxetine (paxil) (2 trials)

sertraline (zoloft) (2 trials)

somatostatin (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 3
# of Trial APIs: 7